Health Canada
Exzell Pharma Inc.
2026-10-07
The handling of standard operating procedures for good manufacturing practices was inadequate.
View the regulator's official sourceBy Agency
Health Canada Findings
by this agency 9,722 findings drawn from 1,877 published documents. The most recent cases are below; the full set is in search.
See all Health Canada findingsWhich agency cited it
Health Canada
9,722
Companies with the most findings
Recent findings
Health Canada
2628709 Alberta Ltd.
2026-09-25
No deficiencies were recorded.
View the regulator's official source
Health Canada
Georgian Reef Pharma
2026-09-24
The written procedures for recalls were inadequate.
See every finding in this document View the regulator's official source
Health Canada
Georgian Reef Pharma
2026-09-24
The assessment, documentation, and/or procedures for considering the resale of returned drugs were inadequate.
See every finding in this document View the regulator's official source
Health Canada
Georgian Reef Pharma
2026-09-24
The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.
See every finding in this document View the regulator's official source
Health Canada
Georgian Reef Pharma
2026-09-24
The handling of standard operating procedures for good manufacturing practices was inadequate.
See every finding in this document View the regulator's official sourceOther agencies
These findings are a record of the moment each document was published. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out — do not read them as the current state; check the regulator's official announcements for the latest status. Counts are measured from public data as of 2026-10-20, and findings are extracted automatically from the regulator's published documents. “View official source” on each case links directly to that document.
